MetabolicTIRZEPATIDE
30MG
$160
Description
Higher concentration Tirzepatide for extended metabolic research protocols. This 30MG formulation provides a larger supply of the groundbreaking dual GIP/GLP-1 receptor agonist for longer study durations or dose-escalation research. Tirzepatide simultaneously activates both GIP and GLP-1 receptors for superior metabolic control, appetite suppression, and body composition improvements compared to single-incretin approaches. The higher concentration supports researchers conducting extended protocols or managing multiple subjects.
Potential Benefits
Research Notes
This higher-dose formulation supports the extended 72-week protocols used in the landmark SURMOUNT clinical trials. Published NEJM data demonstrated maintained efficacy over long treatment durations, with continued improvements in weight and metabolic markers, supporting the utility of higher-concentration formulations for comprehensive research.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.